CEACAM5 and neoplasm: Furthermore, there is growing evidence, that a longitudinal analysis of circulating tumour markers might give evidence on the tumour burden and prognosis of these patients, thus particularly CEA and CA-19-9 are part of standard management in many countries (Lin et al. 2020).